BRIEF⁠—BARDA seeks COVID-19 proposals from drugmakers

The USA’s Biomedical Advanced Research and Development Authority (BARDA) is seeking proposals for advanced research and development activities for COVID-19 therapeutics for both pre-exposure prophylaxis (PrEP) and treatment.

BARDA’s Influenza and Emerging Infectious Diseases Division wants to help bring monoclonal antibody therapeutics to market to help prevent and treat COVID-19.

Drugmakers will receive support in areas such as the manufacturing, US Food and Drug Administration Emergency Use Authorization and regulatory licensure of these products. Interested parties are advised to request a meeting for the opportunity to receive feedback from BARDA staff.